eli lilly - Search News

News

Eli Lilly shares fall

Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell roughly 10% on investor worries that the move could blunt its sales momentum.

STAT · 19h

Eli Lilly shares fall as competitor Novo notches coverage win for obesity drug

Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in the weight loss field.

U.S. News & World Report · 15h

Lilly Star Weight-Loss Drug Zepbound Faces Coverage Challenge From CVS Health

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound

21h

Eli Lilly Beats Q1 Profit Estimates on Strength of Diabetes Drug

FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, ...

15h

Eli Lilly CEO says tariffs are not the answer, urges Trump to move fast on trade deals

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

15hon MSN

Why Eli Lilly Stock Is Sinking Today

Shares of Eli Lilly ( LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as ...

10h

Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'

But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...

18h

Stock Movers: Meta, Eli Lilly, Kohl's

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

1don MSN

Eli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More

Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).

16h

Eli Lilly CEO Urges Trump to Ease Up on Tariffs, Extend 2017 Tax Cuts

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its [tariff rollout]( ...